GlobeNewswire 02.10.2025 HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2025
TeleTrader 01.10.2025 Europe ends higher with attention on CPI, US politics
TeleTrader 01.10.2025 AstraZeneca jumps 9% after US-Pfizer deal
GlobeNewswire 01.10.2025 Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Ser...
GlobeNewswire 01.10.2025 Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
GlobeNewswire 01.10.2025 Aerska Launches with $21 Million in Financing to Develop RNAi Medicines for Diseases of the Brain
TeleTrader 01.10.2025 Europe opens mixed with Eurozone's CPI coming up
GlobeNewswire 29.09.2025 Artelo Biosciences Announces Presentation of Positive Interim Phase 2 CAReS Data on ART27.13 at the ...
TeleTrader 29.09.2025 GSK picks Luke Miels as CEO
TeleTrader 29.09.2025 AstraZeneca to directly list ordinary shares on NYSE
GlobeNewswire 25.09.2025 AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Ri...
GlobeNewswire 22.09.2025 ADC Innovator Myricx Bio Appoints Boston-based Mohit Rawat as CEO and Expands Team in US and UK
GlobeNewswire 17.09.2025 Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Season...
GlobeNewswire 16.09.2025 Quetzal Therapeutics Appoints Dr. Shaad Abedin as Chief Medical Officer
TeleTrader 15.09.2025 Europe closes mostly higher after data
TeleTrader 13.09.2025 AstraZeneca halts £200M Cambridge investment
GlobeNewswire 09.09.2025 Tive Partners with AstraZeneca to Provide a Temperature Tracker for FluMist Home Delivery Program
GlobeNewswire 09.09.2025 With Asthma-Related ER Visits Increasing, AAFA Names 2025 Asthma Capitals
GlobeNewswire 09.09.2025 Scenic Biotech Appoints Dr. Roland W. Bürli as CSO to Advance Pipeline of Modifier Therapies in Neur...
GlobeNewswire 05.09.2025 HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and th...
Newsfile Corp 04.09.2025 Kuehn Law Encourages Investors of Tempus AI, Inc. to Contact Law Firm
GlobeNewswire 03.09.2025 Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2...
GlobeNewswire 03.09.2025 Artelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anor...
GlobeNewswire 02.09.2025 Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire 02.09.2025 FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million